Navigation Links
Sequenom Prices Offering of $110 Million of its 5.00% Convertible Senior Notes Due 2017
Date:9/12/2012

SAN DIEGO, Sept. 12, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM) today announced the pricing of its offering of $110.0 million aggregate principal amount of Convertible Senior Notes due 2017 (the "Convertible Notes") in a private offering.  The sale of the Convertible Notes is expected to close on September 17, 2012, subject to customary closing conditions.  Sequenom also granted to the initial purchasers of the Convertible Notes a 30-day option to purchase up to an additional $20.0 million aggregate principal amount of the Convertible Notes solely to cover over-allotments, if any.  Sequenom intends to use the net proceeds from this offering to fund the commercialization of the MaterniT21 PLUS laboratory-developed test, as well as for other general corporate purposes, which may include research and development expenses, capital expenditures, working capital and general administrative expenses.

The Convertible Notes will be the senior, unsecured obligations of Sequenom.  They will bear interest at a fixed rate of 5.00% per year, payable semiannually in arrears on April 1 and October 1 of each year, beginning April 1, 2013.  Interest on the Convertible Notes will accrue from September 17, 2012.  The Convertible Notes will mature on October 1, 2017, unless earlier converted, redeemed or repurchased.

The Convertible Notes will be convertible at any time prior to the third trading day immediately preceding the maturity date, at the option of the holders, into shares of Sequenom's common stock.  The conversion rate will initially be 216.0644 shares of common stock per $1,000 principal amount of Convertible Notes (equivalent to an initial conversion price of approximately $4.63 per share of common stock), and will be subject to adjustment upon the occurrence of certain events.  In addition, Sequenom will, in certain circumstances
'/>"/>

SOURCE Sequenom, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Sequenom Announces Participation At Two Upcoming Investor Conferences
2. Sequenom, Inc. Files Notice Of Appeal Of Preliminary Injunction Denial
3. Sequenom Addresses Preliminary Injunction Decision, Reaffirms Defense of Patent
4. Sequenom Announces Appointment of Carolyn Beaver to Chief Accounting Officer
5. Sequenom Announces Participation at the Jefferies Global Healthcare Conference
6. Study In Prenatal Diagnosis Finds Sequenom CMMs MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets
7. Sequenom Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
8. Sequenom Announces 2011 Operational Highlights and Early 2012 Outlook
9. Sequenom Named to NASDAQ Global Select Market
10. Sequenom Announces Participation at the 23rd Annual Piper Jaffray Healthcare Conference
11. Sequenom to Host Analyst Day on Monday, November 14, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 31, 2014 Having access to safe ... uphill battle in many corners of the globe. It’s ... community in northwestern Bolivia where many have been sickened ... from Fairfield University’s School of Engineering has been working ... Campesina (UAC), “the united college for the peasants.” A ...
(Date:10/31/2014)... Burlington, MA (PRWEB) October 31, 2014 ... is hosting a free learning webinar to introduce its ... managers, standards directors and biostatisticians. , Launched in September, ... the company's suite of clinical trial automation tools. For ... in a web browser. And by introducing Formations – ...
(Date:10/31/2014)... (PRWEB) October 31, 2014 Stronger ... healthcare, construction, finance and consumer electronics will help ... reason, industry research firm IBISWorld has added a ... its growing industry report collection. , The Biometrics ... for biometric technologies such as fingerprint, iris, retina ...
(Date:10/30/2014)... 30, 2014  Ardelyx, Inc. (NASDAQ: ... cardio-renal, gastrointestinal and metabolic diseases, today announced that ... on Thursday, November 6, 2014. Following the announcement, ... conference call and webcast at 4:30pm ET to ... business update. The live webcast can ...
Breaking Biology Technology:Fairfield University School of Engineering project reduces illness in rural community 2Fairfield University School of Engineering project reduces illness in rural community 3Formedix to Introduce "Revolutionary" Clinical Trial Automation Software with Learning Webinar 2Biometrics Scan Software in the US Industry Market Research Report Now Available from IBISWorld 2Biometrics Scan Software in the US Industry Market Research Report Now Available from IBISWorld 3Ardelyx to Report Third Quarter 2014 Financial Results on November 6, 2014 2
... /Xinhua-PRNewswire/ -- Chindex International,Inc. (Nasdaq: CHDX ), ... Western healthcare products in the People,s,Republic of China, ... fourth quarter which will be reported in the ... filed with the Securities and Exchange Commission,on Monday, ...
... XTL,Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XTL) today ... and Extraordinary General,Meeting (collectively, the "Meetings") scheduled for July ... at the close of business on,June 12, 2008 are ... Meetings. All,shareholders are cordially invited to attend the Meetings ...
... Oncolytics Biotech Inc. (TSX:,ONC, NASDAQ: ONCY), announced today that ... in two separate presentations at the,BIO 2008 International Convention., ... overview of the,Company on Tuesday, June 17th at 3:30 ... Wednesday, June 18th at 4:00 p.m. PT, Dr. Thompson ...
Cached Biology Technology:Chindex International, Inc. Quantifies Fourth Quarter Charges 2Chindex International, Inc. Quantifies Fourth Quarter Charges 3Notification of Record Date for the Annual General Meeting and Extraordinary General Meeting 2Oncolytics Biotech Inc. to Present at BIO 2008 International Convention 2
(Date:10/29/2014)... lose their hair as a consequence of chemotherapy will ... the scalp cooling technology that prevents hair loss. , ... pioneered by global scalp cooling manufacturing company, Paxman Coolers, ... department of the University of Huddersfield. , The research ... has a background in the pharmacology of cancer treatment, ...
(Date:10/29/2014)... registration is open for the Society ... Meeting. SIR 2015 is the one place ... and related health care professionals can come ... science and technologies being presented, discussed and ... in minimally invasive, image-guided medicine, SIR 2015 ...
(Date:10/29/2014)... of chemicals from household and industrial products are in ... But for most of them, scientists have yet to ... the first step toward doing that by estimating which ... method is published in the ACS journal Environmental ... colleagues note that the risks to human health of ...
Breaking Biology News(10 mins):New technology on the way to aid cancer suffers who lose their hair after chemotherapy 2SIR 2015: Interventional radiology shapes tomorrow's medicine 2
... in Proceedings of the National Academy of Sciences, USA, ... the genomics of primitive living fishes such as sharks ... sea squirts. Vertebrates - animals such as ... anatomically and genetically complex of all organisms, but explaining ...
... 11, 2008) Researchers at the Georgia Institute of ... eventually recycle carbon from vehicles to prevent the pollutant ... the atmosphere. Georgia Tech researchers envision a zero emission ... fuels. Technologies to capture carbon dioxide emissions from ...
... Ill. --- In the science world, in the media, ... over how carbon in the atmosphere is affecting global ... Earth is an enormous challenge, but one Northwestern University ... segment -- rivers. Aaron Packman, associate professor of ...
Cached Biology News:Carbon capture strategy could lead to emission-free cars 2Carbon capture strategy could lead to emission-free cars 3Carbon capture strategy could lead to emission-free cars 4Studying rivers for clues to global carbon cycle 2Studying rivers for clues to global carbon cycle 3
Kit containing MACS equipment and reagents for immunopurification of proteins....
... biomarker discovery projects require screening through ... distinguish clinically relevant data from normal ... Manager is now available to help ... and data flood inherent to biomarker ...
This free-standing laminar flow hood provides a vertical flow of HEPA-filtered air to create a clean processing area. It includes a fluorescent light and motorized sliding shield. Options include wor...
This modular laminar flow hood forces air through a 99.99% efficient HEPA filter to create a clean processing area. Configurations are available with vertical or horizontal flow; options include a wo...
Biology Products: